#United States #New York #Securities Fraud #Rosen Law Firm #Semler Scientific

Introduction

The recent class action lawsuit initiated by The Rosen Law Firm presents an intriguing opportunity for investors who purchased securities of Semler Scientific, Inc. (NASDAQ: SMLR) during the period from March 10, 2021, to April 15, 2025. The lawsuit highlights serious allegations of securities fraud, and investors are encouraged to participate to potentially recover losses without incurring upfront costs. This article delves into the details, the implications for SMLR investors, and the steps to participate in the lawsuit.

Background of the Lawsuit

On September 3, 2025, The Rosen Law Firm announced that it had officially filed a class action lawsuit aimed at protecting the rights of investors in Semler Scientific, Inc. The suit arises from claims that Semler made materially false representations and omitted crucial information regarding a significant investigation by the United States Department of Justice (DOJ). Throughout the stated Class Period, the company allegedly failed to disclose the DOJ's investigation into possible violations of the False Claims Act (FCA), which significantly impacts investor trust and company valuation.

Key Allegations

According to the lawsuit, the primary allegations against Semler Scientific include:
1. Failure to Disclose Investigations: Semler did not reveal the ongoing material investigation by the DOJ, which poses substantial risks related to compliance and financial stability. Instead, they discussed the FCA’s implications in hypothetical terms.
2. Misleading Public Statements: Throughout the Class Period, Semler’s public statements were deemed materially misleading, leading to adverse outcomes once the truth emerged, which negatively affected investor confidence and stock prices. When the details finally surfaced, the stock suffered a decline, causing substantial financial damages to investors.

How to Participate

For those who purchased Semler Scientific securities during the specified Class Period, the process to join the ongoing class action lawsuit is straightforward. Here are the essential steps:

• - Visit the Rosen Law Firm's Website: Interested parties can fill out the necessary submission form available at Rosen Legal.
• - Contact Legal Counsel: For personalized assistance, investors are advised to contact Phillip Kim, Esq., toll-free at 866-767-3653 or send an email to [email protected].
• - Act Before Deadlines: It is vital to note that if you wish to be designated as a lead plaintiff in the class action, a motion must be filed by October 28, 2025. A lead plaintiff represents the interests of the entire class in the litigation, ensuring that investors have a voice throughout the proceedings.

About The Rosen Law Firm

The Rosen Law Firm is a globally recognized legal entity specializing in protecting the rights of shareholders and investors. With a commendable track record, the firm has achieved numerous settlements in securities class action cases, recovering hundreds of millions of dollars on behalf of its clients. Their achievements include:

• - Settling the largest securities class action against a Chinese firm, marking a pivotal moment in investor rights protection.
• - Ranking consistently among the top firms for securities class action settlements, providing assurance to potential class members about the firm’s capabilities and expertise.

Notable Attorneys

The firm is led by accomplished attorney Laurence Rosen, who has been recognized as a significant figure in the plaintiffs' bar. With many team members acknowledged by industry authorities, Rosen Law Firm positions itself as a leader in the field, equipped to navigate complex legal landscapes for the benefit of investors.

Current Status and Future Implications

As it stands, no class has been certified yet, meaning investors must be proactive in selecting legal representation if they wish to participate actively. Investors have the option to either join the class action or choose to remain absent as a class member, potentially losing the chance for recovery. Joining the class action does not require the payment of out-of-pocket costs through a contingency fee structure, making it accessible for many.

Conclusion

For investors in Semler Scientific, this lawsuit offers a significant opportunity to seek compensation for potential losses due to alleged securities fraud. The time to act is now—those who purchased shares during the Class Period should evaluate their position and consider joining the class action. For further updates and information, following The Rosen Law Firm on social media platforms can provide essential insights into the developments of this case.